Shotlee LogoShotlee
Blog
Download on theApp Store
Become aBeta Tester
Skip to main content
Must Ozempic Be Used Indefinitely After Starting? UK Surgeon Details Consequences of Discontinuing GLP-1 Medications - Featured image
Health

Must Ozempic Be Used Indefinitely After Starting? UK Surgeon Details Consequences of Discontinuing GLP-1 Medications

Ozempic, a GLP-1 agonist, has surged in popularity for rapid weight loss, mimicking natural hormones to curb hunger and aid glucose management. However, concerns arise about temporary effects and weight rebound upon cessation. Dr. Karan Rajan explains the implications, emphasizing lifestyle adjustments for sustainable health without perpetual medication reliance.

Shotlee·January 13, 2026·Updated Jan 27, 2026·3 min read
Share:

Over the past few years, the demand for Ozempic as an aid in shedding pounds has skyrocketed. Numerous celebrities worldwide have experienced remarkable reductions in weight within brief periods thanks to its effects.

Although Ozempic represents the brand name, the active substance is known as GLP-1 or GLP-1 agonists. This abbreviation stands for glucagon-like peptide-1 receptor agonists, which, per Harvard Health, replicate the GLP-1 hormone naturally produced in the esophagus after meals.

GLP-1 stimulates insulin secretion from the pancreas, facilitating the movement of glucose from the blood into cells for fuel and sustenance. The primary mechanism behind weight reduction involves the medication's influence on the brain, where it diminishes appetite, and on the stomach, where it slows digestion.

Nonetheless, growing worries exist regarding the short-lived nature of GLP-1 drugs, as users report regaining shed pounds shortly after halting treatment. On January 12, Dr. Karan Rajan, a surgeon based in the UK and creator of health-related content, addressed this issue via Instagram.

As per Dr. Rajan, numerous people who discontinued GLP-1 medications have experienced a return of the weight they previously lost.

"Research involving more than 9,000 participants indicated that individuals who ceased taking newer GLP-1 drugs saw a weight increase of roughly 0.8 kilograms, or 1.8 pounds, each month," he noted. "Typically, they reverted to their initial weight within approximately 1.5 years."

Yet, the physician views this weight restoration not as a shortcoming of the pharmaceuticals. He maintains that GLP-1s perform precisely as intended, and the regained pounds merely illustrate obesity's characteristics as a persistent, recurring ailment.

Track your medication journey

Join thousands using Shotlee to track GLP-1 medications.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Become aBeta Tester

Dr. Rajan portrays the widespread adoption of GLP-1s for weight control as a "warning sign" highlighting the absence of a holistic strategy toward managing weight.

"Upon withdrawing the stimulus from a GLP-1, physiological processes return to their inherent configurations. Moreover, the forces driving obesity are formidable," he remarked. "The harsh reality is that GLP-1s do not constitute remedies. They fail to resolve weight issues miraculously. Instead, they resemble medications for hypertension or statins. Ceasing use eliminates their benefits."

For those using GLP-1 drugs who aim to alter their long-term wellness path without eternal reliance, adopting behavioral shifts is essential. This encompasses maintaining "muscle mass, conduct, rest, dietary fiber, protein intake, stress levels, and insulin responsiveness," according to Dr. Rajan.

Regarding the query on whether GLP-1 drugs must be consumed perpetually, Dr. Rajan clarifies, "Consider it akin to eczema. Certain individuals can evade triggers and cope adequately devoid of drugs. Others may require sporadic soothing treatments for flare-ups. And a subset might demand constant daily pharmaceuticals indefinitely. GLP-1s adhere to identical principles."

Health tracking apps like Shotlee can assist in monitoring key metrics such as insulin sensitivity during these lifestyle transitions.

Readers are reminded: This piece serves solely informational ends and does not replace expert medical counsel. Consult your physician for any inquiries concerning health matters.

Original source: Hindustan Times

View original article →
#Ozempic#GLP-1 drugs#weight loss#Dr Karan Rajan#obesity#medication effects#lifestyle changes
  1. Home
  2. Blog
  3. Must Ozempic Be Used Indefinitely After Starting? UK Surgeon Details Consequences of Discontinuing GLP-1 Medications

Related Articles

Zydus Launches Semaglutide in Reusable Pen After Patent Expiry: Prices to Fall
GLP-1 Medications

Zydus Launches Semaglutide in Reusable Pen After Patent Expiry: Prices to Fall

Zydus Lifesciences is set to revolutionize semaglutide access in India with a reusable adjustable pen device after the patent expires on March 20. Brands like SEMAGLYN™, MASHEMA™, and ALTERMET™ promise easier dosing and lower prices around ₹3,500-4,000 per month. This move could expand GLP-1 therapy for Type 2 diabetes and obesity amid rising demand.

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations
GLP-1 Medications

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations

Midlife weight gain is hitting millennial stars hard, but many are turning to Ozempic and other GLP-1s for help. Celebrities including Amy Schumer, Golnesa 'GG' Gharachedaghi, and Serena Williams have openly admitted to using these medications, sharing their triumphs, side effects, and transformations. Discover their stories and the science behind these popular drugs.

SNAC in Ozempic and Wegovy Tablets Raises Gut Health Questions, Study Finds
GLP-1 Medications

SNAC in Ozempic and Wegovy Tablets Raises Gut Health Questions, Study Finds

New research uncovers potential effects of SNAC—the hidden ingredient enabling Ozempic and Wegovy tablets—on gut health. In a 21-day animal study, repeated exposure led to shifts in harmful gut bacteria, elevated inflammation, and depleted cognitive proteins. While not proving harm in humans, findings urge caution as oral semaglutide use surges.

Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Get Started

Resources

  • Health Blog
  • Support Center
  • System Status

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with ♥ for the community